Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global 23-Valent Pneumococcal Polysaccharide Vaccine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global 23-Valent Pneumococcal Polysaccharide Vaccine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Single Dose Vial
Pre-filled Syringe
Segmented by End User/Segment
For Children (2-10)
For Person (10-64)
For The Old (≥65)
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
MSD
Sanofipasteur
CDIBP
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Status and Forecast (2016-2027) 1.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Supply by Company 2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Company 2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Company 2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Company 2.4 23-Valent Pneumococcal Polysaccharide Vaccine Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Market Status by Category 3.1 23-Valent Pneumococcal Polysaccharide Vaccine Category Introduction 3.1.1 Single Dose Vial 3.1.2 Pre-filled Syringe 3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market by Category 3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Category (2016-2021) 3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Category (2016-2021) 3.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Market Status by End User/Segment 4.1 23-Valent Pneumococcal Polysaccharide Vaccine Segment by End User/Segment 4.1.1 For Children (2-10) 4.1.2 For Person (10-64) 4.1.3 For The Old (≥65) 4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market by End User/Segment 4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by End User/Segment (2016-2021) 4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by End User/Segment (2016-2021) 4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Status by Region 5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market by Region 5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Region 5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Region 5.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 5.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 5.4 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 5.5 Central & South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 5.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Status6 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 6.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market by Country 6.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Country (2016-2021) 6.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market by Country 7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Country (2016-2021) 7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 8.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market by Country 8.1.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 9.1 Central & South America 23-Valent Pneumococcal Polysaccharide Vaccine Market by Country 9.1.1 Central & South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Country (2016-2021) 9.1.2 Central & South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Status 10.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market by Country 10.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis 11.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channel and Distributors Analysis 11.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channel 11.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors 11.6 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Major Buyers12 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Category and by End User/Segment 12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Category 12.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Forecast by Category 12.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Forecast by Category 12.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Category 12.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by End User/Segment 12.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Forecast by End User/Segment 12.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Forecast by End User/Segment 12.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by End User/Segment13 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Region/Country 13.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Region (2022-2027) 13.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Forecast by Region (2022-2027) 13.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 MSD 14.1.1 Company Information 14.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction 14.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Sanofipasteur 14.2.1 Company Information 14.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction 14.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 CDIBP 14.3.1 Company Information 14.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction 14.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis ...15 Conclusion16 Methodology